Search CommunityWalk:


United Therapeutics Corporation

1040 Spring Street
Silver Spring, MD 20910, USA

Category: Biotechnology/Biopharmaceutical

Used in the following map:

Maryland Biotech Industry Map

United Therapeutics Corporation is a biotechnology company focused on the development and commercialization of unique products to address the unmet medical needs of patients with chronic and life-threatening conditions.

United Therapeutics' has Five Strategic Objectives: develop the best medicines possible from our intellectual property; conduct the most insightful clinical trials of our medicines; achieve superior communication and awareness of its products among physicians; grow its business to be in the top quintile of its peers; achieve its goals by doing the right thing and using the highest ethical standards.

United Therapeutics' pipeline include: Oral Treprostinil for Pulmonary Arterial Hypertension (PAH); Beraprost-MR for PAH; ch14.18 for Neuroblastoma; 3F8 MAb for Neuroblastoma; Oral Trepostinil for PVD; Aviptadil for PAH; 8H9 MAb for Metastatic Brain Cancer; IW001 for IPF and PGD; and Glycobiology Antiviral Agents.

United Therapeutics' products include: Remodulin, a medication used to treat pulmonary arterial hypertension (PAH); Adcirca, the only once-daily phosophodiesterase-5 (PDE-5) inhibitor for Pulmonary Arterial Hypertension (PAH); TYVASO, an inhaled medicine used to treat PAH; CardioPAL®, technologically advanced portable heart monitor etc.

United Therapeutics has collaborations with Eli Lilly & Co, Lee's Pharmaceutical Holdings Ltd, BIOWEST THERAPEUTICS Inc., Memorial Sloan-Kettering Cancer Center, Aradigm Corp, Mochida Pharmaceutical Co., Ltd., etc.